Use of the neurotoxic component of a botulinum toxin

Details for Australian Patent Application No. 2008237541 (hide)

Owner Allergan, Inc.

Inventors Aoki, Roger K.; Grayston, Michael W.; Carlson, Steven R.; Leon, Judith M.

Agent Davies Collison Cave

Pub. Number AU-B-2008237541

Parent 2007202480

Filing date 28 October 2008

Wipo publication date 20 November 2008

Acceptance publication date 13 October 2011

International Classifications

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61P 21/02 (2006.01) Drugs for disorders of the muscular or neuromuscular system

Event Publications

13 November 2008 Complete Application Filed

20 November 2008 Application Open to Public Inspection

  Published as AU-B-2008237541

6 October 2011 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Aoki, Roger K.; Grayston, Michael W.; Carlson, Steven R. and Leon, Judith M.

13 October 2011 Application Accepted

  Published as AU-B-2008237541

9 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008237542-Medical device including a thin metallic film component attached to a polymeric component and associated methods

2008237540-Footwear construction and related method of manufacture